Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Forget NASDAQ for the moment.
What is it going to take for us to even get to $0.50?
Do you think the initiation of human clinicals on the concussion studies can do it?
Do you see ENDV starting human trials on the heart during the same time as concussion trials?
Can ENDV afford to run multiple human clinicals at the same time? (Concussion, heart, MS, maybe Ischemia)
Is it going to take the heart data to be published in a scientific journal to get ENDV noticed?
We are not going to know anything about revenues from Sofpulse sales until 1st Q ER in May. We can't count on revenue support for some time.
Maybe ENDV can prove abuse of power or illegal trading practice from the MMs?
Maybe our next PR will have this as the title:
Endonovo Therapeutics Is Working With a Long-Term Company Investor to Redeem and Restructure the Remaining Convertible Notes on Better Terms in an Ongoing Effort to Protect Shareholder Value
Don't we wish!!!!!
Everyone, go outside tonight and make that a wish on a shooting star.
Looks like management tried the "paid pumper" route for the last PR. Did not seem to do much. Volume increased to 200m and yet we barely closed green.
Concussion story on Yahoo today.
https://www.yahoo.com/sports/nfl-players-wife-details-football-destroyed-husbands-mind-220418905.html
In this article, it is stated NFL made a billion-dollar concussion settlement with players some time ago. NFL had disregarded connections between football and traumatic brain injuries for quite some time. Now they are on the wagon of research. NFL has deep pockets and big PR potential.
Hopefully Endonovo does not take too long to redesign the assets from RGN. We need to strike while the iron is hot.
Let's get those human clinical concussion trials started.
What are we to expect as the next catalyst from ENDV?
The recent heart news has provided further need to a follow-up study needed before human trials.
The tPEMF products acquired from RGN are being redesigned. Who knows how long this will take before they complete this and will be ready for the human clinicals.
Hopefully we will hear something about the ShareIntel analysis and the MM manipulation that is happening with the stock. The MMs would not be able to manipulate this stock as well, if we were to maintain with mostly "long" position holders. I do believe we have this, but unfortunately we have the dilution adding more shares and keeping us longs from holding the advantage. If we keep the shares locked up, it keeps the MMs short and having no choice but to cover.
So, that brings me to the next catalyst we NEED to see: Financing
If ENDV can eliminate this toxic debt and dilution, the MMs will not be able to manipulate this stock as well. We do have a lot of long holders here. We are suffering at the hands of the dilution.
Revenue can assist with eliminating the dilution. If ENDV can sustain themselves with revenue, no need for toxic financing. Since there are many clinicals still needing to be performed before we can count on revenue for those devices, the only source of revenue will be the sales of Sofpulse. We need to see this get ramped up and soon.
It seems there needs to be a media blitz. Advertise. Not only salespeople knocking on doors. Get the word out via more channels of marketing. If there is CMS coverage for Endonovo's device, how can more people/doctors get to know about it?
The Sofpulse seems to be marketed more heavily towards plastic surgeries. Advertise in a media format that will grab the attention of future patients and current doctors.
Let's get the revenue rolling in to help support the operations and the elimination of the toxic notes!!
A strategic investor would help also, but it does not seem apparent ENDV is eager to give up much % of the company for that purpose.
The O/S maxing out and R/S delay is an ideal situation.
BUT, the power to raise A/S is something else that could derail any rally.
Have not kept up with the posts here.
Has there been any commitment by ICLD to NOT raise A/S again?
What are you thoughts on the new details just released of the heart study? Anything new catch your attention?
Spread the word to your scientific buddies. We could use the support of people "in the know" of this research and not just stock investors.
We are in a battle against the manipulating/shorting market makers keeping the stock price so low.
I believe the doctors need to order on behalf of the patient.
IR emails to Steve....
Let's give them some time to digest the emails and produce an overall PR to shareholders.
We have been getting a communication basically every week now since the acquisition. With the quantity of emails they may have received or will be receiving can create the need for a PR.
Thumbs up to those that sent or will send emails to IR.
You are using PEMF device for sinuses?
Tell me more. Have a relative that suffers all the time from sinus issues (mostly allergies I believe). Has tried numerous types of treatments.
I went to the Sofpulse website.
Seems to be 1 device, 1 shape?
Does not appear to be the type of device for wound healing.
It is more for pain and inflammation.
I'm trying to get a better understanding of how someone can use PEMF for wound healing under CMS.
If it's the Sofpulse, how are they treating the wound on the arm (for example) if it's a big looped ring like the Sofpulse?
Did the companies you lost with, that had the R/S, have toxic debt (continued dilution) during the time of R/S?
Where did we end up on the Breakout Board today? Can't see from phone app.
That settles it.
Email campaign to Endonovo.
Name, ticker symbol, CUISP # changes needed.
No R/S unless the toxic debt is eliminated.
Change name from Endonovo Therapeutics to Endonovo Electroceuticals.
Problem solved and name better reflects the business.
It is VERY bad when the company has toxic debt. Eliminate the toxic debt, then a R/S will not be so bad.
Endonovo should make a slight change of their corporate name. That would be the ideal situation. Let's not even mention reverse split while there is dilution.
The name change would require new CUSIP#. THEN the MMs will be required to account for each of the old shares with the new shares.
On a positive note, ENDV has released a PR in each of the last 4 weeks.
The commitment to shareholder communication is holding up so far.
They key is to know how many shares short and what will it take to make them cover? (How many shares on the Ask).
Biotech once posted he thought there would be a short squeeze one day earlier this month and it never happened.
He was basing his analysis on a daily short report.
Is that daily short report website really accurate?
I have heard the only true accurate short report is the one that is posted bi-monthly.
I have never analyzed those short reports and/or websites. Sometime I think the unknowns are just blamed on shorting.
Guess it's time to really look into this.
Send an email to ENDV IR (Steve Barnes). Ask about a ShareIntel update.
If enough of us write an email about the same topic, maybe they release a communication / update about it.
Appears so. See the traditional 10k transactions during that drop.
Share Structure update.
As of this AM, O/S is 320,779,032.
OTC Market's last update is Nov. 15 and was 177,995,907 at that time.
VNDM is still front and center on the Ask.
Once he disappears, will be good to get a new fresh update.
Do you know the process of how someone under Medicare can get the Sofpulse device for a chronic wound?
I have a friend's mother that might qualify for one. Is it a matter of having the doctor prescribe it? What if the Dr. is unaware of it?
How can we educate the Dr. and get one?
That would be great for the ischemia news to piggyback on the heart study.
I did notice that. But how you define soon?
Interesting tactic.
Why are you posting each paragraph as a separate message?
The heart and concussion studies are using different devices for healing. They are not using the Sofpulse for that.
It is definitely NOT bogus.
The detailed results of heart study are due to be release very soon (any day now).
There is also detailed data released already on concussion study of PEMF on rats with concussions. Human trials of the concussion healing will commence this year.
In summary, the heart and concussion PEMF devices are not competing with Actipatch.
This board is a no nonsense mature crowd. We don't overly hype the company or technology as it is slower process to get where we want to be.
It is not a day trade stock.
Slow and steady will win the race.
This year should definitely be the breakout year though.
Yes, definitely lots of potential. This is a real company, with real technology, several patents, and should not be on the OTC much longer.
How did you learn about ENDV?
ENDV has increased their communication this year. Curious to know where and how it is being seen.
And the 3rd one is a NYSE company.
Endonovo is written in an article alongside bigger companies.
People may notice that and think we have the bigger potential for upward movement.
Interesting to see the article is written by Nasdaq Reporter and ENDV is the only OTC stock mentioned.
I'm not familiar with that online news source. Hopefully is reputable and has large subscription base.
I thought Mann's last minute purchase would save the 5, but there was a small 40k T Trade in the end.
Looks like tomorrow will be your day!!
I do not believe dilution is done yet.
I still see VNDM and I see 10k share transactions.
I have not tracked the debt as since they have been pre revenue for so long it was not worth the effort. They have to dilute shares for operational expense.
Now with the future potential revenue stream, it will become more viable to hold them accountable and have less debt and let the revenue support them.
As soon as they get a large investor and/or better financing deal to eliminate the toxic notes.
That is the PR we need to see soon.
We have some posters here that said they would buy more in the 4s. So that 100k should get taken out the moment it hits the 4s.
Oh but then another 100k ask will appear. Then another...then another....
And Mann's purchase was the last transaction. Good for the closing SP but not representative of the day.
Remember the days someone would purposely paint it down in the last seconds?
At least Mann hit the Ask with his little purchases today.